Combination Chemotherapy (FLAG-Ida) With Pivekimab Sunirine (PVEK [IMGN632]) for the Treatment of Newly Diagnosed Adverse Risk Acute Myeloid Leukemia and Other High-Grade Myeloid Neoplasms
Fred Hutchinson Cancer Center
Fred Hutchinson Cancer Center
University of Arizona
Massachusetts General Hospital
Children's Oncology Group
Dana-Farber Cancer Institute
Fred Hutchinson Cancer Center
City of Hope Medical Center
St. Jude Children's Research Hospital
Ossium Health, Inc.
Orca Biosystems, Inc.
Senti Biosciences
OHSU Knight Cancer Institute
Stanford University
St. Jude Children's Research Hospital
Meryx, Inc.
Fred Hutchinson Cancer Center
National Cancer Institute (NCI)
City of Hope Medical Center
National Cancer Institute (NCI)
Johns Hopkins All Children's Hospital
Janssen Research & Development, LLC
M.D. Anderson Cancer Center
Therapeutic Advances in Childhood Leukemia Consortium
Syndax Pharmaceuticals
Stanford University
SWOG Cancer Research Network
M.D. Anderson Cancer Center
Fred Hutchinson Cancer Center
St. Jude Children's Research Hospital
M.D. Anderson Cancer Center
M.D. Anderson Cancer Center
Medical College of Wisconsin
University of Wisconsin, Madison
Nohla Therapeutics, Inc.
M.D. Anderson Cancer Center
Seattle Children's Hospital
Medical College of Wisconsin
National Cancer Institute (NCI)
National Cancer Institute (NCI)
Cancer Research UK
National Cancer Institute (NCI)
Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins
National Cancer Institute (NCI)
National Cancer Institute (NCI)
National Cancer Institute (NCI)
National Cancer Institute (NCI)
Memorial Sloan Kettering Cancer Center
National Cancer Institute (NCI)
Memorial Sloan Kettering Cancer Center
Memorial Sloan Kettering Cancer Center